United States · Funded startup

Who invested in ITeos Therapeutics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$120Mraised across 1 round since 2024, from 1 source

Latest round
Round, $120MMay 2024
Investors
4
See who backed them

The rounds

  1. May 2024

Founders and team

From the SEC filings it signed: 1 on the team.

  • Michel DetheuxExecutive Officer, Directori

On the board, as filediAnsbert GadickeCHris BuyseDavid HallalDetlev BiniszkiewiczJonathan SkipperPriyanka BelawatTim Van Hauwermeiren

Everyone who backed them

RA Capital ManagementPrivate equity1round
Janus Henderson InvestorsPrivate equity1round
InvusPrivate equity1round
RTW Investments LLCGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about ITeos Therapeutics

Who invested in ITeos Therapeutics?

ITeos Therapeutics's investors include RA Capital Management, Janus Henderson Investors, Invus and RTW Investments LLC.

How much has ITeos Therapeutics raised?

ITeos Therapeutics has raised $120M across 1 round since 2024.

When did ITeos Therapeutics last raise?

ITeos Therapeutics's most recent round was an Undisclosed round of $120M in May 2024.

What was ITeos Therapeutics's biggest round?

Its most recent round, $120M in May 2024, is also its largest on record.

Who backed ITeos Therapeutics first?

ITeos Therapeutics's first round on record, in May 2024, was backed by RA Capital Management, Janus Henderson Investors and Invus and 1 others.

What stage is ITeos Therapeutics at?

ITeos Therapeutics's latest named round is an Undisclosed round, in May 2024.

Where is ITeos Therapeutics based?

ITeos Therapeutics is based in the United States.

Companies like ITeos Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.